Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
NCT07226947

Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment

Led by Massachusetts General Hospital · Updated on 2025-12-30

100

Participants Needed

1

Research Sites

79 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

S

Samsung

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to learn if a smartwatch that measures activity level and body composition, combined with exercise reminders, can safely improve strength and muscle mass in people who recently started or are planning to start treatment with incretin therapy (liraglutide, semaglutide, tirzepatide or retatrutide), also known as glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications.

CONDITIONS

Official Title

Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at time of signing informed consent
  • Started treatment with incretin therapy (liraglutide, semaglutide, tirzepatide, or retatrutide) within the past 2 months or planning to start this treatment
  • Switching GLP1-RA therapies due to inadequate prior response are eligible
  • Able to provide informed consent
Not Eligible

You will not qualify if you...

  • Current pregnancy or plans to become pregnant in the next 6 months
  • Body mass index (BMI) less than 25 kg/m2 at screening
  • Unable to participate in a regular physical exercise program
  • Implanted pacemaker
  • Any factors that would interfere with safe completion of the study as judged by the principal investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Diabetes Research Center

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

B

Ben O Brenner, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here